Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Tam S, Yao CMK, Amit M, Gajera M, Luo X, Treistman R, Khanna A, Aashiq M, Nagarajan P, Bell D, El-Naggar A, Migden M, Wong M, Glisson B, Ferrarotto R, Esmaeli B, Rosenthal D, Li G, Weber RS, Myers JN, Gross ND.

JAMA Otolaryngol Head Neck Surg. 2019 Dec 5. doi: 10.1001/jamaoto.2019.3751. [Epub ahead of print]

PMID:
31804658
2.

Sebaceous carcinoma: evidence-based clinical practice guidelines.

Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M.

Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. Review.

PMID:
31797796
3.

Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.

Esmaeli B, Rubin ML, Xu S, Goepfert RP, Curry JL, Prieto VG, Ning J, Tetzlaff MT.

Am J Surg Pathol. 2019 Dec;43(12):1701-1710. doi: 10.1097/PAS.0000000000001344.

PMID:
31425167
4.

Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.

Bakhoum MF, Esmaeli B.

Cancers (Basel). 2019 Jul 27;11(8). pii: E1061. doi: 10.3390/cancers11081061. Review.

5.

International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma.

Hindsø TG, Esmaeli B, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Sjö LD, Vemuganti GK, Thuro BA, Heegaard S.

Br J Ophthalmol. 2019 Jun 8. pii: bjophthalmol-2019-314008. doi: 10.1136/bjophthalmol-2019-314008. [Epub ahead of print]

PMID:
31177189
6.

Inclusion of Histologic Ulceration and Tumor Thickness in Future American Joint Committee on Cancer T Category Definitions for Conjunctival Melanoma.

Esmaeli B.

JAMA Ophthalmol. 2019 Jun 6. doi: 10.1001/jamaophthalmol.2019.1656. [Epub ahead of print] No abstract available.

PMID:
31169882
7.

PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma.

Nagarajan P, El-Hadad C, Gruschkus SK, Ning J, Hudgens CW, Sagiv O, Gross N, Tetzlaff MT, Esmaeli B.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2388-2398. doi: 10.1167/iovs.19-26894.

8.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2019 May;41(5):1546. doi: 10.1002/hed.25738. Epub 2019 Mar 19. No abstract available.

PMID:
30990235
9.

The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region.

Cheung JJC, Esmaeli B, Lam SC, Kwok T, Yuen HKL.

Eye (Lond). 2019 Sep;33(9):1433-1442. doi: 10.1038/s41433-019-0432-0. Epub 2019 Apr 5.

PMID:
30952958
10.

Targeted Biological Drugs and Immune Check Point Inhibitors for Locally Advanced or Metastatic Cancers of the Conjunctiva, Eyelid, and Orbit.

Esmaeli B, Sagiv O.

Int Ophthalmol Clin. 2019 Spring;59(2):13-26. doi: 10.1097/IIO.0000000000000271. Review. No abstract available.

PMID:
30908276
11.

Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.

Xu S, Sagiv O, Rubin ML, Sa HS, Tetzlaff MT, Nagarajan P, Ning J, Esmaeli B.

JAMA Ophthalmol. 2019 May 1;137(5):537-542. doi: 10.1001/jamaophthalmol.2019.0238. Erratum in: JAMA Ophthalmol. 2019 May 1;137(5):587.

PMID:
30869769
12.

Predictors of Local Recurrence for Eyelid Sebaceous Carcinoma: Questionable Value of Routine Conjunctival Map Biopsies for Detection of Pagetoid Spread.

Sa HS, Tetzlaff MT, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Sep/Oct;35(5):419-425. doi: 10.1097/IOP.0000000000001343.

PMID:
30865067
13.

Long-term Outcomes of Globe-Preserving Surgery with Proton Beam Radiation for Adenoid Cystic Carcinoma of the Lacrimal Gland.

Esmaeli B, Frank SJ.

Am J Ophthalmol. 2019 May;201:83-84. doi: 10.1016/j.ajo.2018.12.014. Epub 2019 Jan 25. No abstract available.

PMID:
30686477
14.

Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.

Zhou C, Wu F, Chai P, Shi Y, Ye J, Shi X, Tan J, Ding Y, Luo Y, Esmaeli B, Jia R, Fan X.

J Am Acad Dermatol. 2019 Jun;80(6):1608-1617.e1. doi: 10.1016/j.jaad.2018.12.053. Epub 2019 Jan 9.

PMID:
30639290
15.

Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.

Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, Bell D, Routbort M, Hudgens CW, Ivan D, Kim TB, Chen K, Eterovic AK, Shaw K, Prieto VG, Yemelyanova A, Esmaeli B.

Clin Cancer Res. 2019 Feb 15;25(4):1280-1290. doi: 10.1158/1078-0432.CCR-18-1688. Epub 2018 Nov 12.

PMID:
30420449
16.

Orbital Lymphoma-An International Multicenter Retrospective Study.

Olsen TG, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Sjö LD, Vemuganti GK, Thuro BA, Heegaard S.

Am J Ophthalmol. 2019 Mar;199:44-57. doi: 10.1016/j.ajo.2018.11.002. Epub 2018 Nov 10.

PMID:
30419193
17.

Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma.

Sagiv O, Bell D, Guo Y, Su S, Wester ST, Jiang K, Yin VT, Shinder R, Hayek B, Kim HJ, Tetzlaff MT, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Mar/Apr;35(2):148-154. doi: 10.1097/IOP.0000000000001189.

PMID:
30371551
18.

Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.

Sagiv O, Ding S, Ferrarotto R, Glisson B, Altan M, Johnson F, Elamin Y, Thakar SD, Nagarajan P, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug;35(4):350-353. doi: 10.1097/IOP.0000000000001251.

PMID:
30365473
19.

Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.

Sagiv O, Thakar SD, Kandl TJ, Ford J, Sniegowski MC, Hwu WJ, Esmaeli B.

JAMA Ophthalmol. 2018 Nov 1;136(11):1236-1241. doi: 10.1001/jamaophthalmol.2018.3488.

20.

High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma.

Kandl TJ, Sagiv O, Curry JL, Ning J, Ma J, Hudgens CW, Van Arnam J, Wargo JA, Esmaeli B, Tetzlaff MT.

Oncoimmunology. 2018 Jul 26;7(9):e1475874. doi: 10.1080/2162402X.2018.1475874. eCollection 2018.

21.

Generation of customized orbital implant templates using 3-dimensional printing for orbital wall reconstruction.

Kang S, Kwon J, Ahn CJ, Esmaeli B, Kim GB, Kim N, Sa HS.

Eye (Lond). 2018 Dec;32(12):1864-1870. doi: 10.1038/s41433-018-0193-1. Epub 2018 Aug 28.

22.

Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.

Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, Kandl TJ, Esmaeli B.

Br J Ophthalmol. 2019 Jul;103(7):980-984. doi: 10.1136/bjophthalmol-2018-312635. Epub 2018 Aug 21.

PMID:
30131380
23.

Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.

Sagiv O, Thakar SD, Manning JT, Kandl TJ, Fayad LE, Fowler N, Hagemeister FB, Fanale MA, Pinnix CC, Samaniego F, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 May/Jun;35(3):243-246. doi: 10.1097/IOP.0000000000001215.

PMID:
30124609
24.

Intraoperative lagophthalmos formula for levator resection in congenital ptosis.

Kang S, Seo JW, Ahn CJ, Esmaeli B, Sa HS.

Br J Ophthalmol. 2019 Jun;103(6):802-804. doi: 10.1136/bjophthalmol-2018-311945. Epub 2018 Jul 26.

PMID:
30049800
25.

The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.

Jager MJ, Brouwer NJ, Esmaeli B.

Ophthalmology. 2018 Aug;125(8):1139-1142. doi: 10.1016/j.ophtha.2018.03.011. No abstract available.

PMID:
30032793
26.

Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma.

Sagiv O, Nagarajan P, Ferrarotto R, Kandl TJ, Thakar SD, Glisson BS, Altan M, Esmaeli B.

Br J Ophthalmol. 2019 Jun;103(6):775-780. doi: 10.1136/bjophthalmol-2018-312277. Epub 2018 Jul 18.

27.

Periocular Ecchymoses in Neuroblastoma Metastatic to the Orbit.

Sagiv O, Stewart J, Esmaeli B.

Ophthalmology. 2018 Jul;125(7):983. doi: 10.1016/j.ophtha.2018.03.033. No abstract available.

PMID:
29935671
28.

Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients.

Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):50-52. doi: 10.1097/IOP.0000000000001161.

PMID:
29927883
29.

Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual.

Ding S, Sagiv O, Guo Y, Kandl TJ, Thakar SD, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):38-41. doi: 10.1097/IOP.0000000000001133.

PMID:
29877957
30.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Ju Lee H, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2018 Jun;40(6):1335. doi: 10.1002/hed.25149. Epub 2018 Feb 21. No abstract available.

PMID:
29851218
31.

Reply: Defining the Role of Secondary Intention Healing in Full-Thickness Lid Margin Defects.

Chang EI, Esmaeli B, Butler CE.

Plast Reconstr Surg. 2018 May;141(5):786e-787e. doi: 10.1097/PRS.0000000000004305. No abstract available.

PMID:
29697642
32.

Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients.

Woo KI, Sagiv O, Han J, Frank SJ, Kim YD, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):570-574. doi: 10.1097/IOP.0000000000001106.

PMID:
29634603
33.

Non-incisional eyelid everting suture technique for treating lower lid epiblepharon.

Seo JW, Kang S, Ahn C, Esmaeli B, Sa HS.

Br J Ophthalmol. 2018 Nov;102(11):1504-1509. doi: 10.1136/bjophthalmol-2017-311635. Epub 2018 Mar 21.

PMID:
29563109
34.

A 60-year-old woman with an asymptomatic left lacrimal gland mass found incidentally.

Thakar SD, Sagiv O, Tetzlaff MT, El-Naggar A, Debnam JM, Kandl TJ, Esmaeli B.

Digit J Ophthalmol. 2017 Oct 18;23(4):27-29. doi: 10.5693/djo.03.2017.07.001. eCollection 2017. No abstract available.

35.

Reply: The Value of Secondary Intention Healing in Eyelid Reconstruction: Response to Recent CME Article by Chang, Esmaeli, and Butler - Content Needs to be Evidence-Based.

Chang EI, Esmaeli B, Butler CE.

Plast Reconstr Surg. 2018 Jan 18. doi: 10.1097/PRS.0000000000004305. [Epub ahead of print] No abstract available.

PMID:
29381552
36.

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.

Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT; TCGA Research Network, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager MJ, Coupland SE, Esmaeli B, Kandoth C, Woodman SE.

Cancer Cell. 2018 Jan 8;33(1):151. doi: 10.1016/j.ccell.2017.12.013. No abstract available.

37.

Desmoplastic Melanoma of the Periorbital Region.

Thakar S, Kandl T, Sagiv O, Tripathy D, Tetzlaff MT, Kapur S, Myers J, Hwu WJ, Jaber BMY, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):e48-e52. doi: 10.1097/IOP.0000000000001015.

PMID:
29194286
38.

Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer.

Sagiv O, Thakar SD, Kandl TJ, Kontoyiannis DP, Debnam JM, Esmaeli B.

Ophthalmology. 2018 Feb;125(2):318-320. doi: 10.1016/j.ophtha.2017.10.006. Epub 2017 Nov 8. Review. No abstract available.

PMID:
29128228
39.

Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.

Knudsen MKH, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Khong JJ, McKelvie PA, Mulay K, Ralfkiaer E, Sjö LD, Vemuganti GK, Thuro BA, Curtin J, Heegaard S.

JAMA Ophthalmol. 2017 Dec 1;135(12):1367-1374. doi: 10.1001/jamaophthalmol.2017.4810.

40.

Eyelid Reconstruction.

Chang EI, Esmaeli B, Butler CE.

Plast Reconstr Surg. 2017 Nov;140(5):724e-735e. doi: 10.1097/PRS.0000000000003820. Review.

PMID:
29068942
41.

Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach.

Bengu Cobanoglu H, Hanna EY, Bell D, Esmaeli B.

Curr Oncol Rep. 2017 Oct 18;19(12):80. doi: 10.1007/s11912-017-0638-x. Review.

PMID:
29043531
42.

Rituximab Monotherapy Is Effective in Treating Orbital Necrobiotic Xanthogranuloma.

Sagiv O, Thakar SD, Morrell G, Tetzlaff MT, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb;34(1):e24-e27. doi: 10.1097/IOP.0000000000000988.

PMID:
28863117
43.

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.

Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT; TCGA Research Network, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager MJ, Coupland SE, Esmaeli B, Kandoth C, Woodman SE.

Cancer Cell. 2017 Aug 14;32(2):204-220.e15. doi: 10.1016/j.ccell.2017.07.003. Erratum in: Cancer Cell. 2018 Jan 8;33(1):151.

44.

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.

Qin Y, Petaccia de Macedo M, Reuben A, Forget MA, Haymaker C, Bernatchez C, Spencer CN, Gopalakrishnan V, Reddy S, Cooper ZA, Fulbright OJ, Ramachandran R, Wahl A, Flores E, Thorsen ST, Tavera RJ, Conrad C, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Amaria RN, Hwu P, Wargo JA, Lazar AJ, Patel SP.

Oncoimmunology. 2017 May 8;6(6):e1321187. doi: 10.1080/2162402X.2017.1321187. eCollection 2017.

45.

Systematic genomic and translational efficiency studies of uveal melanoma.

Johnson CP, Kim IK, Esmaeli B, Amin-Mansour A, Treacy DJ, Carter SL, Hodis E, Wagle N, Seepo S, Yu X, Lane AM, Gragoudas ES, Vazquez F, Nickerson E, Cibulskis K, McKenna A, Gabriel SB, Getz G, Van Allen EM, 't Hoen PAC, Garraway LA, Woodman SE.

PLoS One. 2017 Jun 8;12(6):e0178189. doi: 10.1371/journal.pone.0178189. eCollection 2017.

46.

Clinical Presentation and Anatomical Location of Orbital Plasmacytomas.

Thuro BA, Sagiv O, Shinder R, Debnam JM, Ozgur O, Ng JD, Rootman D, Thomas SK, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2018 May/Jun;34(3):258-261. doi: 10.1097/IOP.0000000000000939.

PMID:
28582371
47.

An Update on Tumors of the Lacrimal Gland.

Andreasen S, Esmaeli B, Holstein SL, Mikkelsen LH, Rasmussen PK, Heegaard S.

Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):159-172. doi: 10.22608/APO.201707. Review.

PMID:
28399336
48.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2017 Jun;39(6):1095-1100. doi: 10.1002/hed.24717. Epub 2017 Apr 3. Erratum in: Head Neck. 2018 Jun;40(6):1335. Head Neck. 2019 May;41(5):1546.

49.

Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual.

Ford J, Thakar S, Thuro B, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct;33(5):317-324. doi: 10.1097/IOP.0000000000000901. Review.

PMID:
28350693
50.

Lymphoma of the Eyelid - An International Multicenter Retrospective Study.

Svendsen FH, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Ralfkiaer E, Sjö LD, Vemuganti GK, Thuro BA, Curtin J, Heegaard S.

Am J Ophthalmol. 2017 May;177:58-68. doi: 10.1016/j.ajo.2017.02.004. Epub 2017 Feb 14.

PMID:
28209503

Supplemental Content

Loading ...
Support Center